Pharmaceutical Engineering
Home
This Month
August 2005
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31
Month Archive
October 2005
September 2005
August 2005
July 2005
June 2005
RSS Newsfeeds
Pharmaceutical Engineering Main RSS Feed Main Page RSS
Pharmaceutical News RSS Feed Pharmaceutical News RSS
Main Page  »  Pharmaceutical News
« August 27  |  August 30 »
Monday, August 29
View Article  Brain Chemistry and the Placebo Effect
by Alex Hsieh on behalf of Professor Henry Wang on Mon 29 Aug 2005 05:09 PM EDT
To date all studies of the placebo effect have relied on anecdotal data, viz., qualitative responses as reported by the patient. But a new study that explored brain chemistry.... By David Appell

Link to Article

trblogs.com
Leave Comment  |  Trackbacks (1)  |  Permanent Link  |  Cosmos
View Article  CDERWEEK 8/22 - 26/2005
by Alex Hsieh on behalf of Professor Henry Wang on Mon 29 Aug 2005 05:07 PM EDT
[Skip navigation]U.S. Food and Drug AdministrationFDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
CDERWEEK Logo
Date: August 22 - August 26, 2005

August 26, 2005

August 24, 2005

August 23, 2005

  • New and Generic Drug Approvals
    • Alavert (loratadine) orally disintegrating tablets, Wyeth Consumer, Formulation Revision
    • Alphagan P (brimonidine tartrate) ophthalmic solution, Allergan, , Approval
    • Clozapine Tablets, Caraco Pharma, New Strength
    • Copegus (ribavirin) in combo w/Pegasys (peginterferon alfa-2a), Hoffman-La Roche, Labeling Revision
    • Fludeoxyglucose F 18 Injection, North Shore LIJ Research, Approval
    • Micro-K LS Packets (potassium chloride) Extended-release Liquid, KV Pharma, Labeling Revision
    • NEVANAC (nepafenac) ophthalmic suspension, Alcon, Approval
    • Zolpidem Tartrate Tablet, Caraco Pharma, Tentative Approval

August 22, 2005

We welcome any feedback or suggestions. webmaster@cder.fda.gov. If you prefer to subscribe to the previous text-only version, please send us a message.

 

---------------------------------------------To subscribe or to unsubscribe from CDERWEEKwww.fda.gov/cder/cdernew/listserv.html
---------------------------------------------

CDER Home PageContact CDERFDA Home PageHHS Home Page

U.S. Food and Drug Administration
Center for Drug Evaluation and Research
1-888-INFO-FDA (1-888-463-6332)

Leave Comment  |  Trackbacks (39)  |  Permanent Link  |  Cosmos